PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsDNA test may benefit women with hard-to-treat breast cancer

BioNews

DNA test may benefit women with hard-to-treat breast cancer

Published 4 May 2018 posted in News and appears in BioNews 948

Author

Dr Jamie Heather

PET BioNews

Genetic testing could reveal a subset of patients with aggressive breast cancer who would benefit from a non-standard treatment, a clinical trial has found...

Genetic testing could reveal a subset of patients with aggressive breast cancer who would benefit from a non-standard treatment, a clinical trial has found. 

Patients with certain genes responded twice as well to treatment with the alternative drug carboplatin, according to the trial, published last week in the journal Nature Medicine. The study was a randomised controlled phase III trial, with 376 patients taking part in the study from 74 hospitals across the UK. 

The usual hormone drugs and targeted therapies for breast cancer act on three surface proteins. Tumours that lack all three receptors are known as triple-negative breast cancers and are among the hardest to treat. The standard treatment for triple-negative patients in the UK is the chemotherapy drug docetaxel. 

These results, however, show that triple negative patients with mutations in their BRCA1 or BRCA2 genes – which increase the risk of developing breast cancer – did better when receiving carboplatin. 

In this trial, two-thirds of triple-negative patients with faulty BRCA1 or BRCA2 genes showed a positive response to carboplatin, compared with only a third to docetaxel. A third of patients who did not have the faulty genes responded to carboplatin. This finding could help some triple-negative breast cancer patients. 

The researchers believe that the differences are due to how the two drugs work. Docetaxel attacks part of the machinery that cells use to divide, while carboplatin directly binds to and interferes with DNA itself. As the BRCA1 and BRCA2 genes are usually involved in repairing damaged DNA, the researchers believe that a tumour in a patient with a less functional version of either BRCA gene is more susceptible to carboplatin, as less of the DNA damage it causes can be repaired.

About 15 percent of breast cancer cases are triple negative, of which five to 15 percent are likely to have BRCA1 or BRCA2 mutations. It is not currently standard practice to test women with triple-negative breast cancer for BRCA mutations, something that the authors of this study believe should change.  

'Using this simple test enables us to guide treatment for women within this type of breast cancer,' said Professor Andrew Tutt of the Institute of Cancer Research in London and lead author of the study. 'This is a great example of using personalised genetics to repurpose a chemotherapy drug into a targeted treatment.'

Related Articles

PET BioNews
News
10 August 2018 • 1 minute read

Five genes linked to triple-negative breast cancer found

by Jen Willows

A study has identified five genes that are associated with an aggressive form of breast cancer...

PET BioNews
News
8 June 2018 • 2 minutes read

Majority of breast cancer patients do not need chemotherapy

by Grace O'Regan

Chemotherapy is not necessary to treat the most common type of breast cancer in 69 percent of cases, a new study has shown...

PET BioNews
News
18 May 2018 • 2 minutes read

Breast cancer drug works in half the time

by Christie Whitehouse

A new study indicates that an important drug used to treat breast cancer is just as effective when the course of treatment is shortened by half.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 May 2018 • 2 minutes read

10 new genetic tests available each day, US study finds

by Julianna Photopoulos

Every day, about 10 new genetic tests come to market in the US, a study has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 May 2018 • 2 minutes read

CRISPR study finds resistance mutations to key cancer drugs

by Hannah Tippett Simpson

DNA mutations that give tumours resistance to a new class of breakthrough breast and ovarian cancer drugs have been discovered...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 January 2018 • 2 minutes read

Screening all women over 30 for BRCA could prevent 64,000 cancers

by Dr Molly Godfrey

The blanket screening of all women over 30 for genetic mutations which cause breast and, or ovarian cancer could prevent more cancers and be more cost effective than current approaches, according to a new study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 November 2017 • 2 minutes read

BRCA screening could prevent 1000 cases of breast cancer a year

by Dr Loredana Guglielmi

Researchers have introduced new criteria to screen for BRCA gene mutations that could prevent more than 10,000 cases of cancer and save more than 2000 lives in the next decade...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
8 November 2017 • 3 minutes read

Seventy-two new gene targets for breast cancer found

by Annabel Slater

Two studies have discovered 72 new genetic variants associated with the risk of developing breast cancer...

PET BioNews
News
30 June 2017 • 2 minutes read

Ovarian cancer drug could treat BRCA-related breast cancer

by Dr Loredana Guglielmi

A drug treatment for ovarian cancer has shown success against inherited breast cancer...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« US Court of Appeals hears CRISPR patent case

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856